Wright, C.Hellard, M.Alimentary Pharmacology & TherapeuticsHiggs P, Wright C, Hellard M. Letter: new treatments for hepatitis C have implications for quality of life in people who inject drug. Aliment Pharmacol Ther 2016; 43: 840-1.
Update the new progress in hepatitis C virus testing and treatment, clarify the testing process in different testing scenarios, introduce new testing technologies, processes, and strategies... Recently, the reporter learned from the China Center for Disease Control and Prevention that the China Center...
Charlie Rice, the Maurice R. and Corinne P. Greenberg Professor in Virology at The Rockefeller University, has been working for decades to develop just that; in fact, his previous research lead to the development of the cure for hepatitis C infection that first became available ...
WELLINGTON, Feb. 1 (Xinhua) -- Tens of thousands of New Zealanders suffering from hepatitis C are set to benefit from a life-saving cure for the disease which is available from Friday. Decision of the Pharmaceutical Management Agency (PHARMAC) to fund new drug Maviret is a big step forward...
Hepatitis C virus (HCV) affects approx. 3% of the world's population and accounts for ca 300000 deaths per year. 80% of individuals with HCV develop chroni... SummerHunt - 《Nursing for Womens Health》 被引量: 0发表: 0年 EASL recommendation on treatment hepatitis C 2018 - what is ne...
Hepatitis C affects >3 million people in the United States, and often leads to end-stage liver disease or death. In 2014, several new drugs to treat hepatitic C virus received US Food and Drug Administration approval, with remarkable cure rates exceeding 90%. Medicaid, however, is rationing...
researchers found that Fluvastatin significantly lowered the viral load, or levels of hepatitis C virus, for up to six weeks when used alone. Hepatitis C is the disease that claimed the life of Oklahoma and Yankee baseball great Mickey Mantle. ...
HepatitisTransplantationCirrhosisAntiviralHepatocellular carcinomaAscitesChildsMELDDAAsHepatitis CRapid and dramatic advances in development of the modern generation of direct antiviral agents specific for hepatitis C have occurred over the last 3 years. In this chapter, we discuss the applications of the new...
"The vast majority of hepatitis C infections occur in low- and middle-income countries. This work shows that a simple one-stop-shop approach—where testing and treatment occurs in the community—is highly effective," Professor Hellard said. The study findings support Myanmar's national hepatitis ...
About 250 to 350 million people worldwide are chronically infected with hepatitis B virus (HBV), and about 700000 patients per year die of HBV-related cirrhosis or hepatocellular carcinoma (HCC). Several anti-viral agents, such as interferon and nucleos(t)ide analogues (NAs), have been used...